Product Information
ATROVENT 17 MCG HFA INHALER is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $22.7663 per GM under NDC 00597008717. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the ipratropium bromide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
17 ug/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597008717
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021527On Market Since
5/1/2005
Pharmacological Classes
Price Statistics
The NADAC for ATROVENT 17 MCG HFA INHALER has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.7663 per GM |
|---|---|
| All-time high | $35.1533 (Jun 12, 2024) |
| All-time low | $16.2887 (Nov 28, 2013) |
| 52-week high | $22.7976 |
| 52-week low | $22.7663 |
| Median price | $26.7426 |
| Average price | $27.0137 |
| Largest weekly change | -35.0% (Jan 8, 2025) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ipratropium bromide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ATROVENT 17 MCG HFA INHALER?
The current National Average Drug Acquisition Cost (NADAC) for ATROVENT 17 MCG HFA INHALER, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $22.7663 per GM (NDC 00597008717), effective Jun 24, 2026.
How has the price of ATROVENT 17 MCG HFA INHALER changed over time?
Over the history we have for it, the NADAC for ATROVENT 17 MCG HFA INHALER has risen 39.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ATROVENT 17 MCG HFA INHALER?
Since Nov 28, 2013, the NADAC for ATROVENT 17 MCG HFA INHALER has ranged from a low of $16.2887 (Nov 28, 2013) to a high of $35.1533 (Jun 12, 2024), with a median of $26.7426 per GM.
Are there cheaper alternatives to ATROVENT 17 MCG HFA INHALER?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ATROVENT 17 MCG HFA INHALER, so no direct lower-cost alternative is listed.
Who manufactures ATROVENT 17 MCG HFA INHALER?
ATROVENT 17 MCG HFA INHALER (NDC 00597008717) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification